PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

indacaterol vs olodaterol

Side-by-side comparison of indacaterol and olodaterol Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
indacaterol Long-Acting Beta-2 Agonist (LABA)
olodaterol Long-Acting Beta-2 Agonist (LABA)
Type
indacaterol Prescription
olodaterol Prescription
Summary
indacaterol

UTIBRON NEOHALER is a medicine that helps people with COPD breathe easier. It contains two medicines that work together to open up your airways.

olodaterol

Striverdi Respimat is a medicine that helps people with COPD breathe easier. It contains olodaterol, which is a long-acting beta-2 agonist (LABA).

What It Treats
indacaterol

UTIBRON NEOHALER is used long-term to treat airflow blockage caused by COPD. COPD is a chronic lung disease that makes it hard to breathe. This medicine helps to open your airways so you can breathe easier. It is not for sudden breathing problems.

olodaterol

Striverdi Respimat is used long-term to treat COPD, including chronic bronchitis and emphysema. It helps to open up the airways in your lungs, making it easier to breathe. This medicine is not for sudden COPD symptoms or for asthma.

How It Works
indacaterol

UTIBRON NEOHALER has two medicines. Indacaterol opens airways by relaxing airway muscles. Glycopyrrolate reduces airway tightening. Together, they help you breathe easier.

olodaterol

Olodaterol is a LABA. It works by relaxing the muscles around your airways. This helps to open them up so air can flow in and out of your lungs more easily.

Common Side Effects
indacaterol
  • Common cold symptoms (nasopharyngitis)
  • High blood pressure (hypertension)
olodaterol
  • Common cold symptoms
  • Cough
  • Back pain
FAERS Reports
indacaterol

No adverse event reports.

olodaterol

No adverse event reports.

Serious Warnings
indacaterol

LABA medicines like UTIBRON NEOHALER can raise the risk of asthma-related death. Because of this risk, you should not take this medication if you have asthma. Do not use UTIBRON NEOHALER to treat sudden COPD symptoms. Do not use with other LABA medicines.

olodaterol

LABAs like olodaterol can raise the risk of asthma-related death if used alone to treat asthma. Striverdi Respimat is not for asthma. Using too much Striverdi Respimat can cause serious heart problems and may be fatal. If you have a bad reaction, like swelling or trouble breathing, stop using Striverdi Respimat and get medical help right away.

Pregnancy
indacaterol

Tell your doctor if you are pregnant or plan to become pregnant. It is not known if UTIBRON NEOHALER will harm your unborn baby. Talk to your doctor about the risks and benefits of using this medicine while pregnant.

olodaterol

Tell your doctor if you are pregnant or plan to become pregnant. Striverdi Respimat should only be used during pregnancy if the benefit outweighs the risk to the baby. It is not known if Striverdi Respimat passes into breast milk.

Also Compare — Nearby Drugs

How to Read This indacaterol vs olodaterol Comparison

indacaterol is classified in the Long-Acting Beta-2 Agonist (LABA) drug class, while olodaterol sits within the Long-Acting Beta-2 Agonist (LABA) class. Because both drugs share the same classification, they are often considered interchangeable in theory — but clinical outcomes rarely track that cleanly. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, indacaterol has 0 submissions while olodaterol has 0. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between indacaterol and olodaterol — always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.